Showing results (41-50 of 117) with videos related to
Sort By:
Pageof 12
Handbook of Experimental Pharmacology|September 1, 2021
Glycaemic Control in DiabetesD Müller-Wieland, J Brandts, M Verket, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 1999
PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular diseaseN Marx, T Bourcier, G K Sukhova, et al.Circulation|June 22, 1999
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cellsN Marx, G K Sukhova, T Collins, et al.Circulation Research|December 1, 1998
Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cellsN Marx, U Schönbeck, M A Lazar, et al.Acta Anaesthesiologica Scandinavica|August 6, 2016
Differences between prolonged weaning patients from medical and surgical intensive care unitsJ Bickenbach, G Marx, C Schmoor, et al.Clinical Laboratory|October 24, 2008
Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery diseaseA Pfützner, N Marx, D Walcher, et al.Zeitschrift Fur Kardiologie|June 9, 2005
Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and childrenL Schwachtgen, M Herrmann, T Georg, et al.Anticancer Research|January 1, 1995
Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysisU Ramp, C D Gerharz, R Engers, et al.Thorax|August 30, 2003
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cellsM Hetzel, D Walcher, M Grüb, et al.Journal of Clinical Gastroenterology|February 6, 1998
Diarrheal epidemics among Rwandan refugees in 1994. Management and outcome in a field hospitalS N Heyman, Y Ginosar, M Shapiro, et al.Pageof 12